These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: 3H-Noradrenaline and 3H-5-hydroxytryptamine release from rat brain slices and its presynaptic alpha-adrenergic modulation after long-term desipramine pretreatment.
    Author: Schoffelmeer AN, Mulder AH.
    Journal: Naunyn Schmiedebergs Arch Pharmacol; 1982 Feb; 318(3):173-80. PubMed ID: 6278332.
    Abstract:
    The electrically-evoked release of 3H-noradrenaline from superfused cortex and hippocampus slices was strongly enhanced (by about 50%) after long-term (4 weeks) pretreatment with desipramine (10 mg/kg, twice daily). The release-enhancing effect of the alpha-receptor antagonist phentolamine was significantly reduced but the inhibitory effects of exogenous noradrenaline and clonidine on 3H-noradrenaline release were virtually unchanged after chronic desipramine treatment. The K+ -induced release of 3H-noradrenaline from superfused synaptosomes obtained from rats pretreated with desipramine was about 25% higher than that from synaptosomes of control animals. However, noradrenaline inhibited the K+ -induced synaptosomal 3H-noradrenaline release to the same extent (viz. by about 55%) in both cases. The release of 3H-5-hydroxytryptamine induced by 26 mM K+ from cortex and hippocampus slices was not affected by chronic pretreatment with desipramine. In addition, no change was observed in the inhibitory effect of noradrenaline o 3H-5-hydroxytryptamine release. It is concluded that long-term pretreatment with desipramine leads to selective changes in the basic mechanism(s) of noradrenaline release rather than to changes in the sensitivity of presynaptic alpha-adrenoceptors.
    [Abstract] [Full Text] [Related] [New Search]